Markel Group Inc. boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 2.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,430 shares of the company’s stock after purchasing an additional 1,750 shares during the period. Markel Group Inc.’s holdings in HCA Healthcare were worth $39,009,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the company. Palisade Asset Management LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth $26,000. Holos Integrated Wealth LLC bought a new stake in HCA Healthcare in the fourth quarter worth $29,000. Ares Financial Consulting LLC bought a new position in HCA Healthcare during the fourth quarter valued at about $31,000. Cedar Mountain Advisors LLC bought a new stake in shares of HCA Healthcare during the 1st quarter worth about $33,000. Finally, MCF Advisors LLC raised its stake in shares of HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after acquiring an additional 49 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.
Analyst Ratings Changes
HCA has been the topic of a number of recent analyst reports. Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 7th. Oppenheimer dropped their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Robert W. Baird lowered their price target on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Sanford C. Bernstein cut their price objective on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a research report on Thursday, June 4th. Finally, JPMorgan Chase & Co. lowered their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $497.14.
HCA Healthcare Stock Performance
Shares of NYSE:HCA traded down $2.56 on Friday, hitting $406.45. 1,651,230 shares of the company were exchanged, compared to its average volume of 1,367,535. The company’s 50 day moving average price is $397.56 and its two-hundred day moving average price is $460.39. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The firm has a market capitalization of $90.17 billion, a price-to-earnings ratio of 13.98, a PEG ratio of 1.29 and a beta of 1.12.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period last year, the business earned $6.45 earnings per share. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.
HCA Healthcare Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.73%.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
